Abattis Bioceuticals Corp Stock Today
| ATTBF Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Abattis Bioceuticals is trading at 1.0E-4 as of the 18th of January 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.0E-4. Abattis Bioceuticals has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of November 2024 and ending today, the 18th of January 2025. Click here to learn more.
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ABATTIS BIOCEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.. The company has 477.8 M outstanding shares. More on Abattis Bioceuticals Corp
Moving together with Abattis Pink Sheet
Moving against Abattis Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Abattis Pink Sheet Highlights
| Thematic Idea | Marijuana (View all Themes) |
| Business Concentration | Marijuana, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Abattis Bioceuticals Corp [ATTBF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 473.03 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abattis Bioceuticals's market, we take the total number of its shares issued and multiply it by Abattis Bioceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Abattis Bioceuticals Corp classifies itself under Pharmaceuticals sector and is part of Health Care industry. The entity has 477.8 M outstanding shares.
Abattis Bioceuticals Corp has accumulated about 2.4 M in cash with 9.41 M of positive cash flow from operations.
Check Abattis Bioceuticals Probability Of Bankruptcy
Ownership AllocationAbattis Bioceuticals holds a total of 477.8 Million outstanding shares. Almost 99.98 percent of Abattis Bioceuticals outstanding shares are held by general public with 0.018 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Abattis Ownership Details
Abattis Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Abattis Bioceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Abattis Bioceuticals Corporate Management
| Douglas LLB | Advisor | Profile | |
| BBA CA | CEO Pres | Profile | |
| CIRC CRIA | Advisor | Profile | |
| Nicole Breitinger | Corporate Secretary | Profile | |
| Shawn Balaghi | Head Devel | Profile | |
| Jim Carter | Head Advisory | Profile |
Other Information on Investing in Abattis Pink Sheet
Abattis Bioceuticals financial ratios help investors to determine whether Abattis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Abattis with respect to the benefits of owning Abattis Bioceuticals security.